Biomarkers and Diagnostic Tests in MASH: Executive Summary
High-level reference tables comparing diagnostic cutoffs, clinical strengths, technical limitations, and intended clinical applications.
No single liver test measures everything at once — some measure fat (steatosis), some measure scarring (fibrosis), and some combine lab values to flag whether you need a specialist visit. These five summary pages let you compare the major tests side by side before diving into the individual test pages.
Summary comparison of routine liver enzymes, platelet count, and the FIB-4 index for primary screening and risk stratification.
Side-by-side comparison of quantitative ultrasound attenuation (eg, CAP >=288 dB/m) and MRI-PDFF (>=5%) for assessing hepatic fat.
Executive overview of the FDA-authorized Enhanced Liver Fibrosis (ELF) blood test, staging cutoffs (<7.7 to >=11.3), strengths, and confounders.
Comparison of ultrasound-based elastography (eg, VCTE kPa stages) and Magnetic Resonance Elastography (MRE kPa stages) for liver fibrosis.
Visual matrix mapping 12 major MASH tests across four clinical roles: referral stratification, steatosis only, fibrosis only, and dual steatosis + fibrosis.